Siklos (hydroxyurea) now available through ProCare Pharmacy Care's Siklos At Home program | oneSCDvoice
  • Join Today!

Become a member and connect with:

  • An Active Online Community
  • Articles and Advice on SCD
  • Help Understanding Clinical Trials

Siklos (hydroxyurea) now available through ProCare Pharmacy Care’s Siklos At Home program


 

Medunik USA announced today that Siklos® (hydroxyurea), the first and only hydroxyurea-based treatment FDA-approved for pediatric patients with sickle cell anemia, is now available through the Siklos At Home™ program.

“The recent launch of Siklos® represents an important milestone in Medunik USA’s mission to support patients with rare diseases – in this case, sickle cell anemia,” said Dean Hopkins, the company’s General Manager. “We are looking forward to introducing this treatment to pediatric patients with sickle cell anemia and committed to providing Siklos® at the lowest possible cost to all patients, whether they are cash-paying or have commercial or Medicaid healthcare coverage, through the Siklos At Home™ program, offered through our specialty pharmacy, ProCare Pharmacy Care.”

Through Siklos At Home™, commercially insured patients can receive Siklos® for as little as $0 copay per prescription. Patients who are not insured or whose insurance does not cover Siklos® can pay as little as $99 for 60 tablets or $149 for 90 tablets.

https://www.onescdvoice.com/wp-content/uploads/2018/09/procare.jpg